Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome ... ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro for the treatment of atrial fibrillation, or AF, in patients with chronic heart failure, or HF. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.4 | 13.7931034483 | 10.15 | 11.59 | 9.58 | 232154 | 10.72175432 | CS |
| 4 | 0.7 | 6.45161290323 | 10.85 | 12.11 | 9.44 | 227883 | 10.71777022 | CS |
| 12 | -10.95 | -48.6666666667 | 22.5 | 23.57 | 9.44 | 320421 | 14.82883266 | CS |
| 26 | -17.23 | -59.8679638638 | 28.78 | 31.13 | 9.44 | 227421 | 18.37634782 | CS |
| 52 | -17.45 | -60.1724137931 | 29 | 31.13 | 9.44 | 216064 | 18.41113484 | CS |
| 156 | -17.45 | -60.1724137931 | 29 | 31.13 | 9.44 | 216064 | 18.41113484 | CS |
| 260 | -17.45 | -60.1724137931 | 29 | 31.13 | 9.44 | 216064 | 18.41113484 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
